Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.17 trillion and total revenue of $110.17 billion.
Market Cap
1.17T
Revenue
110.17B
Profits
-39.71B
PE Ratio
n/a
Profit Margin
-36.05%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 110.81B | -1.37% | 1,364,285 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 76.55B | -1.05% | 505,374 | 14.34B |
| 3 | ARGX | argenx SE | 52.04B | -1.49% | 255,485 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.46B | -3.98% | 1,022,842 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 35.57B | 0.24% | 206,871 | 5.34B |
| 6 | RVMD | Revolution Medicines, Inc. | 31.16B | -2.14% | 5,701,860 | - |
| 7 | INSM | Insmed Incorporated | 30.82B | -2.69% | 2,160,901 | 606.42M |
| 8 | RPRX | Royalty Pharma plc | 27.97B | -0.45% | 2,107,813 | 2.38B |
| 9 | BNTX | BioNTech SE | 25.82B | 2.66% | 647,120 | 3.37B |
| 10 | MRNA | Moderna, Inc. | 21.69B | 0.77% | 5,092,571 | 1.94B |
| 11 | ROIV | Roivant Sciences Ltd. | 20.89B | -0.68% | 5,740,302 | 13.31M |
| 12 | INCY | Incyte Corporation | 18.97B | -1.83% | 1,616,847 | 5.14B |
| 13 | SMMT | Summit Therapeutics Inc. | 18.93B | 15.63% | 6,793,286 | - |
| 14 | GMAB | Genmab A/S | 17.31B | -3.41% | 1,240,257 | 3.72B |
| 15 | BBIO | BridgeBio Pharma, Inc. | 15.03B | -0.24% | 917,778 | 502.08M |
| 16 | ASND | Ascendis Pharma A/S | 15.01B | 0.51% | 559,895 | 845.52M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.43B | -2.03% | 1,873,900 | 943.71M |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 12.18B | -0.75% | 2,303,305 | 4.27B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.04B | 1.19% | 198,217 | 958.40M |
| 20 | EXEL | Exelixis, Inc. | 11.53B | 0.23% | 2,069,848 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.40B | -2.12% | 1,459,410 | 3.22B |
| 22 | ABVX | ABIVAX Société Anonyme | 9.62B | 0.81% | 748,645 | 5.37M |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.52B | -4.19% | 1,952,892 | 1.09B |
| 24 | AXSM | Axsome Therapeutics, Inc. | 9.42B | 0.01% | 410,135 | 638.50M |
| 25 | TECH | Bio-Techne Corporation | 8.97B | -1.93% | 2,034,917 | 1.22B |
| 26 | PCVX | Vaxcyte, Inc. | 8.95B | 2.89% | 1,363,830 | - |
| 27 | PRAX | Praxis Precision Medicines, Inc. | 8.92B | -5.75% | 479,050 | 7.46M |
| 28 | NUVL | Nuvalent, Inc. | 8.17B | -0.85% | 591,160 | - |
| 29 | CYTK | Cytokinetics, Incorporated | 8.06B | 0.08% | 1,168,813 | 88.04M |
| 30 | HALO | Halozyme Therapeutics, Inc. | 7.90B | -2.07% | 1,589,257 | 1.40B |
| 31 | KRYS | Krystal Biotech, Inc. | 7.77B | -1.67% | 224,689 | 389.13M |
| 32 | IBRX | ImmunityBio, Inc. | 7.49B | -6.81% | 17,552,939 | 113.29M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 7.03B | -3.21% | 554,950 | 39.21M |
| 34 | ACLX | Arcellx, Inc. | 6.75B | 0.09% | 434,554 | 22.29M |
| 35 | APGE | Apogee Therapeutics, Inc. | 6.69B | 1.38% | 661,349 | - |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.62B | -1.62% | 417,822 | 46.02M |
| 37 | BLTE | Belite Bio, Inc | 6.22B | -6.35% | 354,501 | - |
| 38 | CNTA | Centessa Pharmaceuticals plc | 6.11B | -0.20% | 2,510,812 | 15.00M |
| 39 | TERN | Terns Pharmaceuticals, Inc. | 6.08B | -0.04% | 4,775,818 | - |
| 40 | CELC | Celcuity Inc. | 6.05B | 1.44% | 1,103,897 | - |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.02B | 0.34% | 763,523 | 189.76M |
| 42 | SYRE | Spyre Therapeutics, Inc. | 5.94B | 1.03% | 2,195,106 | - |
| 43 | PTCT | PTC Therapeutics, Inc. | 5.93B | -2.54% | 1,171,066 | 1.73B |
| 44 | COGT | Cogent Biosciences, Inc. | 5.83B | -0.36% | 1,677,121 | - |
| 45 | MIRM | Mirum Pharmaceuticals, Inc. | 5.78B | -0.56% | 321,547 | 521.31M |
| 46 | CAI | Caris Life Sciences, Inc. | 5.76B | -2.63% | 1,775,682 | 812.03M |
| 47 | SRRK | Scholar Rock Holding Corporation | 5.74B | 1.38% | 2,567,058 | - |
| 48 | ERAS | Erasca, Inc. | 5.67B | 0.16% | 2,917,854 | - |
| 49 | CGON | CG Oncology, Inc. | 5.60B | -1.98% | 1,295,309 | 4.04M |
| 50 | XENE | Xenon Pharmaceuticals Inc. | 5.58B | -0.76% | 976,876 | 7.50M |
| 51 | IMVT | Immunovant, Inc. | 5.57B | -0.29% | 2,143,313 | - |
| 52 | CRSP | CRISPR Therapeutics AG | 5.35B | -1.83% | 1,713,552 | 3.51M |
| 53 | APLS | Apellis Pharmaceuticals, Inc. | 5.22B | 0.05% | 6,291,490 | 1.00B |
| 54 | TGTX | TG Therapeutics, Inc. | 5.07B | -0.87% | 1,823,586 | 616.29M |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 5.06B | -2.99% | 606,532 | 2.04M |
| 56 | CORT | Corcept Therapeutics Incorporated | 4.68B | 0.14% | 901,899 | 761.41M |
| 57 | FOLD | Amicus Therapeutics, Inc. | 4.54B | -0.07% | 3,004,700 | 634.21M |
| 58 | LGND | Ligand Pharmaceuticals Incorporated | 4.45B | -0.82% | 192,228 | 268.09M |
| 59 | VKTX | Viking Therapeutics, Inc. | 4.12B | 0.17% | 1,512,449 | - |
| 60 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.09B | -1.89% | 747,580 | 7.70M |
| 61 | LEGN | Legend Biotech Corporation | 3.90B | 2.73% | 3,666,835 | 1.03B |
| 62 | NAMS | NewAmsterdam Pharma Company N.V. | 3.82B | -2.38% | 798,368 | 22.50M |
| 63 | GPCR | Structure Therapeutics Inc. | 3.79B | -1.38% | 548,122 | - |
| 64 | TVTX | Travere Therapeutics, Inc. | 3.65B | -3.44% | 4,562,074 | 490.73M |
| 65 | ACAD | ACADIA Pharmaceuticals Inc. | 3.62B | -2.34% | 1,677,626 | 1.07B |
| 66 | TNGX | Tango Therapeutics, Inc. | 3.57B | -1.14% | 2,428,489 | 62.38M |
| 67 | TLX | Telix Pharmaceuticals Limited | 3.56B | 0.75% | 304,404 | 803.79M |
| 68 | EWTX | Edgewise Therapeutics, Inc. | 3.55B | -1.72% | 497,904 | - |
| 69 | ORKA | Oruka Therapeutics, Inc. | 3.32B | 2.32% | 1,315,755 | - |
| 70 | DYN | Dyne Therapeutics, Inc. | 3.29B | -0.35% | 1,920,449 | - |
| 71 | DNLI | Denali Therapeutics Inc. | 3.28B | -4.47% | 1,515,701 | - |
| 72 | ALMS | Alumis Inc. | 3.18B | 3.48% | 1,557,056 | 24.05M |
| 73 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.16B | 0.15% | 913,079 | 588.99M |
| 74 | VERA | Vera Therapeutics, Inc. | 3.03B | -2.78% | 931,671 | - |
| 75 | BEAM | Beam Therapeutics Inc. | 3.01B | -1.14% | 1,713,136 | 139.74M |
| 76 | ARQT | Arcutis Biotherapeutics, Inc. | 3.00B | -1.59% | 900,783 | 376.07M |
| 77 | RCUS | Arcus Biosciences, Inc. | 2.96B | -0.46% | 678,451 | 247.00M |
| 78 | TARS | Tarsus Pharmaceuticals, Inc. | 2.88B | -5.68% | 723,333 | 451.36M |
| 79 | RLAY | Relay Therapeutics, Inc. | 2.88B | 4.00% | 3,264,824 | 15.36M |
| 80 | IDYA | IDEAYA Biosciences, Inc. | 2.85B | 1.03% | 1,248,346 | 218.71M |
| 81 | MANE | Veradermics, Incorporated | 2.77B | -7.93% | 519,461 | - |
| 82 | SLNO | Soleno Therapeutics, Inc. | 2.72B | - | 4,154,614 | 190.41M |
| 83 | ELVN | Enliven Therapeutics, Inc. | 2.71B | 3.16% | 1,488,106 | - |
| 84 | CLDX | Celldex Therapeutics, Inc. | 2.66B | -0.03% | 853,187 | 1.55M |
| 85 | IRON | Disc Medicine, Inc. | 2.65B | -1.04% | 260,079 | - |
| 86 | ZLAB | Zai Lab Limited | 2.65B | 1.08% | 1,340,925 | 460.16M |
| 87 | IMNM | Immunome, Inc. | 2.63B | -0.56% | 784,219 | 6.94M |
| 88 | ADMA | ADMA Biologics, Inc. | 2.56B | 0.85% | 4,570,041 | 510.17M |
| 89 | MLYS | Mineralys Therapeutics, Inc. | 2.52B | 0.46% | 1,379,935 | - |
| 90 | KOD | Kodiak Sciences Inc. | 2.49B | -3.74% | 980,006 | - |
| 91 | AAPG | Ascentage Pharma Group International | 2.48B | 0.26% | 540 | 82.08M |
| 92 | NKTR | Nektar Therapeutics | 2.41B | 0.93% | 668,628 | 55.23M |
| 93 | RARE | Ultragenyx Pharmaceutical Inc. | 2.41B | -2.62% | 1,812,338 | 673.00M |
| 94 | DFTX | Definium Therapeutics, Inc. | 2.24B | 1.40% | 2,464,712 | - |
| 95 | SRPT | Sarepta Therapeutics, Inc. | 2.22B | -2.58% | 2,572,242 | 2.20B |
| 96 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | -0.09% | 1,220,026 | 158.18M |
| 97 | ADPT | Adaptive Biotechnologies Corporation | 2.17B | -3.10% | 1,303,071 | 276.98M |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 2.10B | -1.37% | 846,206 | 283.06M |
| 99 | SNDX | Syndax Pharmaceuticals, Inc. | 2.10B | -2.14% | 825,013 | 172.35M |
| 100 | STOK | Stoke Therapeutics, Inc. | 2.09B | -0.56% | 326,762 | 184.42M |
| 101 | MESO | Mesoblast Limited | 2.08B | 2.16% | 229,513 | 65.38M |
| 102 | AGIO | Agios Pharmaceuticals, Inc. | 2.05B | 1.36% | 832,208 | 54.03M |
| 103 | SION | Sionna Therapeutics, Inc. | 2.04B | 0.33% | 817,609 | - |
| 104 | ZYME | Zymeworks Inc. | 2.01B | -1.91% | 335,961 | 105.97M |
| 105 | CAPR | Capricor Therapeutics, Inc. | 1.99B | -1.28% | 849,319 | 11.13M |
| 106 | OCUL | Ocular Therapeutix, Inc. | 1.93B | -0.56% | 2,018,405 | 51.95M |
| 107 | ANAB | AnaptysBio, Inc. | 1.92B | -1.46% | 1,297,753 | 234.60M |
| 108 | RXRX | Recursion Pharmaceuticals, Inc. | 1.90B | -4.00% | 16,375,626 | 74.68M |
| 109 | GLPG | Galapagos NV | 1.90B | -1.03% | 120,947 | 1.31B |
| 110 | TYRA | Tyra Biosciences, Inc. | 1.89B | 0.43% | 1,804,885 | - |
| 111 | RAPP | Rapport Therapeutics, Inc. | 1.89B | 7.71% | 372,640 | - |
| 112 | PHVS | Pharvaris N.V. | 1.88B | -1.24% | 116,916 | - |
| 113 | TRVI | Trevi Therapeutics, Inc. | 1.87B | 1.89% | 1,022,691 | - |
| 114 | PVLA | Palvella Therapeutics, Inc. | 1.78B | -3.46% | 268,734 | - |
| 115 | INVA | Innoviva, Inc. | 1.75B | -1.34% | 768,307 | 411.33M |
| 116 | NRIX | Nurix Therapeutics, Inc. | 1.73B | -1.65% | 888,165 | 71.78M |
| 117 | VCEL | Vericel Corporation | 1.72B | -4.52% | 380,762 | 276.26M |
| 118 | TSHA | Taysha Gene Therapies, Inc. | 1.71B | -0.83% | 4,405,038 | 9.77M |
| 119 | HRMY | Harmony Biosciences Holdings, Inc. | 1.70B | 0.68% | 505,085 | 868.45M |
| 120 | NTLA | Intellia Therapeutics, Inc. | 1.67B | -5.22% | 3,609,671 | 67.67M |
| 121 | NUVB | Nuvation Bio Inc. | 1.67B | -0.21% | 4,548,538 | 62.90M |
| 122 | VIR | Vir Biotechnology, Inc. | 1.65B | -1.24% | 1,253,178 | 68.56M |
| 123 | DMRA | Damora Therapeutics, Inc. | 1.63B | 1.47% | 483,227 | - |
| 124 | OCS | Oculis Holding AG | 1.62B | -0.62% | 206,542 | 1.51M |
| 125 | GENB | Generate Biomedicines, Inc. | 1.61B | 0.88% | 291,397 | 31.89M |
| 126 | IMCR | Immunocore Holdings plc | 1.59B | -0.82% | 269,629 | 400.02M |
| 127 | NBTX | Nanobiotix S.A. | 1.59B | -2.23% | 52,070 | 38.27M |
| 128 | MBX | MBX Biosciences, Inc. | 1.58B | 0.79% | 217,048 | - |
| 129 | BCAX | Bicara Therapeutics Inc. | 1.57B | 0.89% | 387,361 | - |
| 130 | IOVA | Iovance Biotherapeutics, Inc. | 1.57B | -0.52% | 11,014,677 | 263.50M |
| 131 | ARDX | Ardelyx, Inc. | 1.54B | -0.32% | 1,668,879 | 407.32M |
| 132 | BHVN | Biohaven Ltd. | 1.51B | -3.47% | 1,600,034 | - |
| 133 | VRDN | Viridian Therapeutics, Inc. | 1.50B | -1.48% | 1,612,202 | 70.85M |
| 134 | GLUE | Monte Rosa Therapeutics, Inc. | 1.50B | 2.58% | 1,104,570 | 123.67M |
| 135 | ATAI | AtaiBeckley Inc. | 1.49B | 2.25% | 16,706,330 | 4.09M |
| 136 | IMTX | Immatics N.V. | 1.46B | -1.18% | 160,844 | 56.67M |
| 137 | OLMA | Olema Pharmaceuticals, Inc. | 1.44B | -0.06% | 625,031 | - |
| 138 | SVRA | Savara Inc. | 1.43B | -3.92% | 1,196,980 | - |
| 139 | NVAX | Novavax, Inc. | 1.41B | -0.58% | 2,005,999 | 1.12B |
| 140 | PGEN | Precigen, Inc. | 1.40B | 1.28% | 2,355,674 | 9.68M |
| 141 | WVE | Wave Life Sciences Ltd. | 1.38B | -3.56% | 3,003,378 | 42.73M |
| 142 | MAZE | Maze Therapeutics, Inc. | 1.34B | 0.07% | 421,795 | 2.50M |
| 143 | AVBP | ArriVent BioPharma, Inc. | 1.31B | 0.68% | 380,011 | - |
| 144 | ZBIO | Zenas BioPharma, Inc. | 1.29B | 3.37% | 313,830 | 10.00M |
| 145 | MLTX | MoonLake Immunotherapeutics | 1.28B | -1.28% | 860,529 | - |
| 146 | CRVS | Corvus Pharmaceuticals, Inc. | 1.26B | -0.46% | 632,464 | - |
| 147 | MPLT | MapLight Therapeutics, Inc. | 1.26B | 5.99% | 203,164 | - |
| 148 | PHAR | Pharming Group N.V. | 1.24B | -2.64% | 7,695 | 376.13M |
| 149 | EYPT | EyePoint, Inc. | 1.24B | 1.23% | 588,192 | 31.37M |
| 150 | DBVT | DBV Technologies S.A. | 1.23B | -3.01% | 77,535 | 5.64M |
| 151 | INBX | Inhibrx Biosciences, Inc. | 1.21B | -0.59% | 120,680 | 1.30M |
| 152 | CMPX | Compass Therapeutics, Inc. | 1.18B | 11.62% | 7,118,346 | 850.00K |
| 153 | ABCL | AbCellera Biologics Inc. | 1.16B | -0.78% | 2,911,897 | 75.13M |
| 154 | IVA | Inventiva S.A. | 1.16B | -1.92% | 567,442 | 7.94M |
| 155 | SEPN | Septerna, Inc. | 1.12B | -3.63% | 352,207 | 45.95M |
| 156 | GHRS | GH Research PLC | 1.10B | 4.35% | 212,300 | - |
| 157 | GERN | Geron Corporation | 1.08B | - | 8,451,346 | 183.88M |
| 158 | JBIO | Jade Biosciences, Inc. | 1.08B | 13.60% | 673,053 | - |
| 159 | CTMX | CytomX Therapeutics, Inc. | 1.06B | 7.24% | 5,678,475 | 76.20M |
| 160 | XERS | Xeris Biopharma Holdings, Inc. | 1.06B | -1.29% | 1,435,533 | 291.85M |
| 161 | QURE | uniQure N.V. | 1.05B | -2.55% | 1,321,345 | 16.10M |
| 162 | URGN | UroGen Pharma Ltd. | 1.04B | -0.56% | 996,804 | 109.79M |
| 163 | AKTS | Aktis Oncology, Inc. | 1.03B | 2.82% | 356,115 | 6.50M |
| 164 | ORIC | ORIC Pharmaceuticals, Inc. | 1.03B | -0.49% | 1,363,015 | - |
| 165 | ANNX | Annexon, Inc. | 1.02B | -0.31% | 2,413,689 | - |
| 166 | KALV | KalVista Pharmaceuticals, Inc. | 1.00B | -6.23% | 2,265,817 | 73.62M |
| 167 | PHAT | Phathom Pharmaceuticals, Inc. | 1.00B | -1.41% | 810,760 | 175.11M |
| 168 | EVMN | Evommune, Inc. | 964.21M | -0.63% | 277,579 | 13.00M |
| 169 | FTRE | Fortrea Holdings Inc. | 943.42M | 0.40% | 1,524,479 | 2.72B |
| 170 | SANA | Sana Biotechnology, Inc. | 926.03M | 0.87% | 2,058,563 | - |
| 171 | JANX | Janux Therapeutics, Inc. | 924.03M | 1.00% | 623,732 | 10.00M |
| 172 | ABUS | Arbutus Biopharma Corporation | 914.84M | 4.46% | 2,225,178 | 14.08M |
| 173 | ANRO | Alto Neuroscience, Inc. | 913.47M | 2.32% | 321,352 | - |
| 174 | XNCR | Xencor, Inc. | 913.07M | -0.48% | 635,515 | 125.58M |
| 175 | OMER | Omeros Corporation | 902.83M | 2.37% | 1,092,175 | - |
| 176 | CGEM | Cullinan Therapeutics, Inc. | 892.16M | -1.40% | 420,777 | - |
| 177 | SLS | SELLAS Life Sciences Group, Inc. | 885.34M | 0.41% | 3,415,146 | - |
| 178 | MRVI | Maravai LifeSciences Holdings, Inc. | 876.60M | -2.57% | 2,090,971 | 185.74M |
| 179 | TBPH | Theravance Biopharma, Inc. | 864.05M | 0.84% | 526,793 | 107.46M |
| 180 | DRUG | Bright Minds Biosciences Inc. | 851.14M | -1.08% | 198,153 | - |
| 181 | MNKD | MannKind Corporation | 849.19M | -0.72% | 3,025,613 | 348.97M |
| 182 | SGP | SpyGlass Pharma, Inc. | 836.67M | 1.21% | 22,070 | - |
| 183 | SLDB | Solid Biosciences Inc. | 825.53M | 0.84% | 672,656 | - |
| 184 | SPRY | ARS Pharmaceuticals, Inc. | 812.25M | 2.00% | 1,292,774 | 84.28M |
| 185 | VOR | Vor Biopharma Inc. | 811.16M | -4.04% | 724,989 | - |
| 186 | KURA | Kura Oncology, Inc. | 793.54M | -1.22% | 1,045,784 | 67.48M |
| 187 | ALLO | Allogene Therapeutics, Inc. | 785.13M | 9.22% | 28,838,769 | 22.00K |
| 188 | LXRX | Lexicon Pharmaceuticals, Inc. | 779.57M | -1.08% | 1,969,267 | 49.80M |
| 189 | MGTX | MeiraGTx Holdings plc | 772.11M | -15.73% | 4,424,316 | 81.39M |
| 190 | DSGN | Design Therapeutics, Inc. | 771.52M | -1.88% | 563,851 | - |
| 191 | FBRX | Forte Biosciences, Inc. | 769.35M | 0.48% | 201,826 | - |
| 192 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 737.90M | -1.81% | 244,479 | - |
| 193 | RLMD | Relmada Therapeutics, Inc. | 734.22M | -2.51% | 1,855,175 | - |
| 194 | GYRE | Gyre Therapeutics, Inc. | 721.38M | -1.50% | 35,328 | 116.59M |
| 195 | LBRX | LB Pharmaceuticals Inc | 715.46M | -2.88% | 711,834 | - |
| 196 | ARVN | Arvinas, Inc. | 703.57M | 0.27% | 980,860 | 262.60M |
| 197 | DRTS | Alpha Tau Medical Ltd. | 701.44M | 1.14% | 492,293 | - |
| 198 | TENX | Tenax Therapeutics, Inc. | 678.05M | -3.78% | 534,865 | - |
| 199 | OCGN | Ocugen, Inc. | 652.14M | -1.03% | 4,805,963 | 4.41M |
| 200 | PRME | Prime Medicine, Inc. | 649.88M | -3.17% | 1,519,384 | 4.63M |
| 201 | CBIO | Crescent Biopharma, Inc. | 646.01M | -2.51% | 74,109 | 10.84M |
| 202 | ZVRA | Zevra Therapeutics, Inc. | 610.60M | 0.78% | 809,646 | 106.47M |
| 203 | EIKN | Eikon Therapeutics, Inc. | 608.52M | 3.69% | 159,949 | - |
| 204 | PROK | ProKidney Corp. | 588.74M | -2.99% | 842,647 | 893.00K |
| 205 | RIGL | Rigel Pharmaceuticals, Inc. | 586.89M | -0.90% | 413,863 | 294.28M |
| 206 | KYTX | Kyverna Therapeutics, Inc. | 576.14M | 1.38% | 467,448 | - |
| 207 | PRTA | Prothena Corporation plc | 566.32M | -2.77% | 298,913 | 9.68M |
| 208 | CRMD | CorMedix Inc. | 563.63M | -1.38% | 868,599 | 311.71M |
| 209 | TECX | Tectonic Therapeutic, Inc. | 557.29M | -0.03% | 127,401 | - |
| 210 | VSTM | Verastem, Inc. | 556.92M | 0.16% | 2,653,194 | 30.91M |
| 211 | ADCT | ADC Therapeutics SA | 556.45M | 0.23% | 2,206,370 | 81.36M |
| 212 | STTK | Shattuck Labs, Inc. | 555.53M | 2.51% | 286,086 | 1.00M |
| 213 | ACRS | Aclaris Therapeutics, Inc. | 553.20M | 1.27% | 1,108,422 | 7.83M |
| 214 | LYEL | Lyell Immunopharma, Inc. | 552.88M | -0.59% | 57,762 | 36.00K |
| 215 | UPB | Upstream Bio, Inc. | 549.64M | 2.23% | 1,152,806 | 2.85M |
| 216 | ANL | Adlai Nortye Ltd. | 547.60M | 3.32% | 938,624 | 5.00M |
| 217 | AGMB | AgomAb Therapeutics NV | 545.85M | 5.07% | 521,650 | - |
| 218 | ZURA | Zura Bio Limited | 541.77M | 0.35% | 691,205 | - |
| 219 | ENGN | enGene Therapeutics Inc. | 541.27M | 4.12% | 285,474 | - |
| 220 | FULC | Fulcrum Therapeutics, Inc. | 532.14M | -3.15% | 997,598 | 80.00M |
| 221 | IMMX | Immix Biopharma, Inc. | 528.00M | -0.80% | 743,765 | - |
| 222 | VALN | Valneva SE | 521.75M | -1.00% | 27,126 | 205.07M |
| 223 | FDMT | 4D Molecular Therapeutics, Inc. | 513.58M | 2.97% | 837,067 | 85.21M |
| 224 | MDXG | MiMedx Group, Inc. | 509.58M | -11.60% | 3,672,327 | 418.63M |
| 225 | CTNM | Contineum Therapeutics, Inc. | 496.57M | 0.38% | 653,785 | - |
| 226 | ABSI | Absci Corporation | 494.26M | 1.89% | 3,230,238 | 2.80M |
| 227 | LRMR | Larimar Therapeutics, Inc. | 490.33M | -2.28% | 1,186,952 | - |
| 228 | TRDA | Entrada Therapeutics, Inc. | 488.16M | -3.07% | 154,576 | 25.42M |
| 229 | LXEO | Lexeo Therapeutics, Inc. | 487.49M | -3.24% | 479,116 | - |
| 230 | STRO | Sutro Biopharma, Inc. | 486.25M | -1.41% | 195,063 | 102.48M |
| 231 | IVVD | Invivyd, Inc. | 483.59M | - | 1,264,673 | 53.43M |
| 232 | RGNX | REGENXBIO Inc. | 474.36M | -1.82% | 365,730 | 170.44M |
| 233 | XOMA | XOMA Royalty Corporation | 471.98M | -1.30% | 106,328 | 52.15M |
| 234 | ASMB | Assembly Biosciences, Inc. | 465.09M | -1.64% | 175,050 | 72.30M |
| 235 | DNA | Ginkgo Bioworks Holdings, Inc. | 462.75M | 2.05% | 1,471,422 | 170.16M |
| 236 | BNTC | Benitec Biopharma Inc. | 461.07M | -1.03% | 122,118 | - |
| 237 | ALT | Altimmune, Inc. | 456.67M | 3.24% | 2,580,476 | 41.00K |
| 238 | VTVT | vTv Therapeutics Inc. | 456.05M | -2.57% | 32,434 | 17.00K |
| 239 | AVIR | Atea Pharmaceuticals, Inc. | 454.13M | -3.06% | 246,633 | - |
| 240 | AURA | Aura Biosciences, Inc. | 452.90M | -0.42% | 285,749 | - |
| 241 | EPRX | Eupraxia Pharmaceuticals Inc. | 440.89M | -2.70% | 184,860 | - |
| 242 | IPSC | Century Therapeutics, Inc. | 438.52M | -5.79% | 1,220,117 | 109.16M |
| 243 | PRTC | PureTech Health plc | 433.38M | -0.16% | 3,677 | 6.39M |
| 244 | AUTL | Autolus Therapeutics plc | 428.49M | 8.05% | 1,607,148 | 75.39M |
| 245 | RCKT | Rocket Pharmaceuticals, Inc. | 425.58M | 0.52% | 2,474,863 | - |
| 246 | VNDA | Vanda Pharmaceuticals Inc. | 423.21M | -1.51% | 861,957 | 216.11M |
| 247 | CLYM | Climb Bio, Inc. | 421.32M | 1.97% | 378,177 | - |
| 248 | ARMP | Armata Pharmaceuticals, Inc. | 416.88M | -5.64% | 36,204 | 4.90M |
| 249 | IRD | Opus Genetics, Inc. | 409.11M | 0.70% | 437,054 | 14.20M |
| 250 | LCTX | Lineage Cell Therapeutics, Inc. | 408.50M | 0.61% | 866,170 | 14.56M |
| 251 | ENTA | Enanta Pharmaceuticals, Inc. | 408.01M | -3.37% | 83,362 | 66.98M |
| 252 | NGNE | Neurogene Inc. | 399.17M | 6.79% | 359,670 | 925.00K |
| 253 | NAUT | Nautilus Biotechnology, Inc. | 395.51M | -3.85% | 484,906 | - |
| 254 | CABA | Cabaletta Bio, Inc. | 391.86M | 3.53% | 1,795,214 | - |
| 255 | PALI | Palisade Bio, Inc. | 390.09M | -0.43% | 3,075,005 | - |
| 256 | MNPR | Monopar Therapeutics Inc. | 386.14M | -0.36% | 259,912 | - |
| 257 | AVTX | Avalo Therapeutics, Inc. | 385.22M | 8.01% | 793,740 | 59.00K |
| 258 | NAGE | Niagen Bioscience, Inc. | 379.57M | -0.21% | 669,589 | 129.42M |
| 259 | CADL | Candel Therapeutics, Inc. | 377.95M | 0.19% | 1,283,765 | - |
| 260 | XFOR | X4 Pharmaceuticals, Inc. | 376.41M | -4.39% | 332,173 | 35.11M |
| 261 | GLSI | Greenwich LifeSciences, Inc. | 375.46M | 4.59% | 90,367 | - |
| 262 | YDES | YD Bio Limited | 372.70M | -2.57% | 22,002 | 510.36K |
| 263 | OVID | Ovid Therapeutics Inc. | 369.25M | 1.45% | 3,004,269 | 7.25M |
| 264 | PBYI | Puma Biotechnology, Inc. | 368.35M | -3.21% | 335,789 | 228.37M |
| 265 | RZLT | Rezolute, Inc. | 367.71M | -1.39% | 883,624 | - |
| 266 | PRLD | Prelude Therapeutics Incorporated | 365.63M | -19.75% | 830,827 | 12.14M |
| 267 | NMRA | Neumora Therapeutics, Inc. | 364.08M | -2.91% | 684,679 | - |
| 268 | IMRX | Immuneering Corporation | 360.12M | -3.13% | 1,045,771 | - |
| 269 | SLN | Silence Therapeutics plc | 358.98M | 4.40% | 349,470 | 559.00K |
| 270 | BCYC | Bicycle Therapeutics plc | 358.29M | -2.65% | 227,841 | 72.59M |
| 271 | DMAC | DiaMedica Therapeutics Inc. | 356.70M | 0.61% | 128,971 | - |
| 272 | ZNTL | Zentalis Pharmaceuticals, Inc. | 356.07M | -6.34% | 1,883,043 | 26.87M |
| 273 | SRZN | Surrozen, Inc. | 348.28M | -5.31% | 88,982 | 3.48M |
| 274 | NGEN | NervGen Pharma Corp. | 336.67M | -1.89% | 220,391 | - |
| 275 | EDIT | Editas Medicine, Inc. | 327.87M | -0.59% | 1,376,589 | 40.52M |
| 276 | CLLS | Cellectis S.A. | 318.68M | 4.40% | 14,406 | 79.59M |
| 277 | AVXL | Anavex Life Sciences Corp. | 315.08M | 4.94% | 817,236 | - |
| 278 | NBP | NovaBridge Biosciences | 308.78M | 2.69% | 1,903,132 | - |
| 279 | ABEO | Abeona Therapeutics Inc. | 306.92M | -0.37% | 459,998 | 5.82M |
| 280 | ACIU | AC Immune SA | 304.55M | -2.23% | 580,456 | 4.51M |
| 281 | PLYX | Polaryx Therapeutics, Inc. | 302.52M | -1.08% | 51,856 | - |
| 282 | LENZ | LENZ Therapeutics, Inc. | 302.26M | 0.63% | 1,136,775 | 19.09M |
| 283 | ARTV | Artiva Biotherapeutics, Inc. | 299.32M | 33.08% | 1,278,004 | 251.00K |
| 284 | CHRS | Coherus Oncology, Inc. | 293.01M | 1.06% | 1,645,020 | 42.17M |
| 285 | IKT | Inhibikase Therapeutics, Inc. | 289.72M | -5.03% | 841,199 | 1.00 |
| 286 | FHTX | Foghorn Therapeutics Inc. | 285.28M | -0.21% | 100,016 | 30.91M |
| 287 | ELDN | Eledon Pharmaceuticals, Inc. | 283.35M | 13.03% | 3,045,835 | - |
| 288 | CCCC | C4 Therapeutics, Inc. | 282.98M | 0.35% | 1,338,496 | 35.95M |
| 289 | ALEC | Alector, Inc. | 281.42M | -1.16% | 561,130 | 21.05M |
| 290 | TARA | Protara Therapeutics, Inc. | 277.45M | -1.54% | 426,036 | - |
| 291 | NERV | Minerva Neurosciences, Inc. | 275.77M | 1.78% | 185,301 | - |
| 292 | SABS | SAB Biotherapeutics, Inc. | 275.48M | -3.21% | 308,996 | 114.70K |
| 293 | HELP | Cybin Inc. | 275.20M | - | 1,293,604 | - |
| 294 | CGEN | Compugen Ltd. | 273.26M | - | 480,046 | 72.76M |
| 295 | OBIO | Orchestra BioMed Holdings, Inc. | 261.59M | -2.19% | 96,347 | 33.48M |
| 296 | MIST | Milestone Pharmaceuticals Inc. | 256.34M | -5.00% | 3,242,393 | 1.55M |
| 297 | ACHV | Achieve Life Sciences, Inc. | 256.08M | 35.49% | 14,059,327 | - |
| 298 | ADAG | Adagene Inc. | 254.38M | 0.79% | 284,068 | 7.67M |
| 299 | ARCT | Arcturus Therapeutics Holdings Inc. | 251.26M | 2.55% | 408,517 | 82.03M |
| 300 | SLGL | Sol-Gel Technologies Ltd. | 246.22M | -5.61% | 42,925 | 19.39M |
| 301 | VYGR | Voyager Therapeutics, Inc. | 236.01M | -1.74% | 342,219 | 40.37M |
| 302 | CAMP | Camp4 Therapeutics Corporation | 233.64M | -1.96% | 86,776 | 3.50M |
| 303 | ELTX | Elicio Therapeutics, Inc. | 231.79M | 6.96% | 169,511 | - |
| 304 | KROS | Keros Therapeutics, Inc. | 231.09M | 0.09% | 222,024 | 244.06M |
| 305 | CDXS | Codexis, Inc. | 230.81M | 3.25% | 1,308,037 | 70.39M |
| 306 | OABI | OmniAb, Inc. | 225.86M | 5.41% | 735,705 | 18.67M |
| 307 | NVCT | Nuvectis Pharma, Inc. | 221.21M | -1.76% | 19,919 | - |
| 308 | ALXO | ALX Oncology Holdings Inc. | 221.10M | - | 511,341 | - |
| 309 | MDWD | MediWound Ltd. | 219.77M | -0.87% | 73,143 | 16.96M |
| 310 | FENC | Fennec Pharmaceuticals Inc. | 217.19M | -3.08% | 221,577 | 44.64M |
| 311 | MGNX | MacroGenics, Inc. | 216.74M | -3.12% | 405,059 | 149.50M |
| 312 | ENLV | Enlivex Ltd. | 210.94M | 8.37% | 1,802,990 | - |
| 313 | CNTX | Context Therapeutics Inc. | 210.40M | -8.76% | 930,170 | - |
| 314 | CRBU | Caribou Biosciences, Inc. | 207.77M | -2.27% | 2,089,140 | 11.16M |
| 315 | PRQR | ProQR Therapeutics N.V. | 205.45M | -2.01% | 243,665 | 19.19M |
| 316 | SGMT | Sagimet Biosciences Inc. | 201.70M | 1.98% | 288,625 | - |
| 317 | TNXP | Tonix Pharmaceuticals Holding Corp. | 200.72M | -1.46% | 486,405 | 13.11M |
| 318 | WHWK | Whitehawk Therapeutics, Inc. | 199.64M | 8.46% | 590,804 | 7.15M |
| 319 | NKTX | Nkarta, Inc. | 199.61M | 15.70% | 1,688,365 | - |
| 320 | MENS | Jyong Biotech Ltd. | 199.17M | -1.52% | 100,408 | - |
| 321 | CNTN | Canton Strategic Holdings, Inc. | 197.73M | -2.51% | 874,710 | - |
| 322 | KPTI | Karyopharm Therapeutics Inc. | 195.23M | 1.17% | 226,071 | 146.07M |
| 323 | DTIL | Precision BioSciences, Inc. | 194.30M | -1.70% | 213,456 | 34.26M |
| 324 | KRRO | Korro Bio, Inc. | 194.27M | -1.54% | 85,281 | 6.39M |
| 325 | ABOS | Acumen Pharmaceuticals, Inc. | 194.25M | -1.10% | 327,158 | - |
| 326 | HURA | TuHURA Biosciences, Inc. | 188.19M | -3.58% | 1,310,663 | - |
| 327 | PLX | Protalix BioTherapeutics, Inc. | 185.31M | -3.36% | 763,249 | 52.74M |
| 328 | REPL | Replimune Group, Inc. | 180.83M | -3.95% | 8,806,634 | - |
| 329 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 179.85M | 1.40% | 177,056 | - |
| 330 | AGEN | Agenus Inc. | 178.17M | -3.93% | 795,228 | 114.20M |
| 331 | HRTX | Heron Therapeutics, Inc. | 177.22M | -1.75% | 1,358,099 | 154.90M |
| 332 | UNCY | Unicycive Therapeutics, Inc. | 174.14M | -1.00% | 309,618 | - |
| 333 | TLSA | Tiziana Life Sciences Ltd | 171.02M | 0.75% | 170,073 | - |
| 334 | RNAC | Cartesian Therapeutics, Inc. | 169.13M | 6.51% | 301,035 | 2.80M |
| 335 | CNTB | Connect Biopharma Holdings Limited | 169.00M | 2.05% | 245,643 | 64.00K |
| 336 | BDTX | Black Diamond Therapeutics, Inc. | 167.28M | 1.74% | 840,960 | 70.00M |
| 337 | TNYA | Tenaya Therapeutics, Inc. | 162.12M | -2.97% | 2,125,015 | - |
| 338 | FATE | Fate Therapeutics, Inc. | 159.28M | 6.20% | 1,229,219 | 6.65M |
| 339 | ORMP | Oramed Pharmaceuticals Inc. | 156.12M | 1.05% | 88,788 | 2.00M |
| 340 | MOLN | Molecular Partners AG | 155.55M | -0.48% | 2,158 | 856.30K |
| 341 | SPRO | Spero Therapeutics, Inc. | 155.15M | 1.52% | 552,122 | 66.80M |
| 342 | HUMA | Humacyte, Inc. | 151.77M | -7.13% | 5,291,557 | 2.04M |
| 343 | KLRS | Kalaris Therapeutics, Inc. | 151.10M | 12.27% | 180,022 | - |
| 344 | IPHA | Innate Pharma S.A. | 149.10M | -4.14% | 55,523 | 10.57M |
| 345 | GALT | Galectin Therapeutics Inc. | 148.77M | -11.72% | 538,141 | - |
| 346 | ACOG | Alpha Cognition Inc. | 144.80M | -1.48% | 73,624 | 10.22M |
| 347 | BMEA | Biomea Fusion, Inc. | 139.54M | -2.03% | 1,082,936 | - |
| 348 | IMUX | Immunic, Inc. | 130.46M | -9.91% | 6,805,033 | - |
| 349 | EQ | Equillium, Inc. | 125.19M | -3.41% | 203,605 | 4.39M |
| 350 | KZIA | Kazia Therapeutics Limited | 124.78M | 9.20% | 282,961 | 1.27M |
| 351 | ONCY | Oncolytics Biotech Inc. | 123.10M | -3.64% | 708,390 | - |
| 352 | GNLX | Genelux Corporation | 122.91M | -2.46% | 58,609 | 8.00K |
| 353 | NTHI | NeOnc Technologies Holdings, Inc. | 119.51M | -2.71% | 38,477 | 39.99K |
| 354 | SEER | Seer, Inc. | 115.66M | 4.59% | 556,824 | 16.58M |
| 355 | CRDF | Cardiff Oncology, Inc. | 115.54M | -0.59% | 667,526 | 593.00K |
| 356 | PEPG | PepGen Inc. | 115.42M | -2.91% | 1,053,094 | - |
| 357 | ANTX | AN2 Therapeutics, Inc. | 112.99M | -3.68% | 313,332 | - |
| 358 | SGMO | Sangamo Therapeutics, Inc. | 111.85M | -1.85% | 3,310,636 | 39.55M |
| 359 | VANI | Vivani Medical, Inc. | 110.89M | 14.91% | 1,480,097 | - |
| 360 | CBUS | Cibus, Inc. | 108.93M | -0.69% | 389,832 | 3.64M |
| 361 | AARD | Aardvark Therapeutics, Inc. | 108.86M | -1.77% | 149,918 | - |
| 362 | ALDX | Aldeyra Therapeutics, Inc. | 108.33M | -1.64% | 1,309,602 | - |
| 363 | PYXS | Pyxis Oncology, Inc. | 106.81M | -0.58% | 122,387 | 13.86M |
| 364 | VRCA | Verrica Pharmaceuticals Inc. | 106.68M | 5.08% | 153,889 | 35.58M |
| 365 | PMN | ProMIS Neurosciences, Inc. | 106.18M | -3.74% | 88,398 | - |
| 366 | COYA | Coya Therapeutics, Inc. | 105.09M | -1.10% | 82,142 | 7.95M |
| 367 | GOSS | Gossamer Bio, Inc. | 102.66M | -2.99% | 5,149,565 | 48.47M |
| 368 | TTRX | Turn Therapeutics Inc. | 101.88M | -0.29% | 32,027 | - |
| 369 | CGTX | Cognition Therapeutics, Inc. | 99.18M | 1.83% | 1,267,010 | - |
| 370 | INO | Inovio Pharmaceuticals, Inc. | 95.05M | -2.52% | 2,285,985 | 65.34K |
| 371 | ANIX | Anixa Biosciences, Inc. | 94.88M | -3.41% | 82,213 | - |
| 372 | SPRB | Spruce Biosciences, Inc. | 93.18M | -2.05% | 19,372 | 697.00K |
| 373 | RANI | Rani Therapeutics Holdings, Inc. | 91.64M | -4.27% | 826,480 | 1.63M |
| 374 | EXOZ | eXoZymes, Inc. | 89.03M | -3.14% | 6,245 | -700.00 |
| 375 | PYPD | PolyPid Ltd. | 88.93M | -1.27% | 44,712 | - |
| 376 | IFRX | InflaRx N.V. | 86.75M | -0.83% | 391,751 | 34.44K |
| 377 | GANX | Gain Therapeutics, Inc. | 86.60M | -4.21% | 453,871 | - |
| 378 | ACET | Adicet Bio, Inc. | 86.53M | 1.64% | 132,135 | - |
| 379 | COEP | Coeptis Therapeutics Holdings, Inc. | 85.32M | 5.54% | 62,740 | 1.36M |
| 380 | FLNA | Filana Therapeutics, Inc. | 85.02M | 9.32% | 991,206 | - |
| 381 | CSBR | Champions Oncology, Inc. | 84.71M | -1.29% | 1,881 | 57.95M |
| 382 | MCRB | Seres Therapeutics, Inc. | 84.65M | -0.11% | 58,374 | 789.00K |
| 383 | QTTB | Q32 Bio Inc. | 83.68M | -6.08% | 131,685 | 53.74M |
| 384 | OKYO | OKYO Pharma Limited | 83.44M | -3.64% | 55,032 | - |
| 385 | NRXP | NRx Pharmaceuticals, Inc. | 82.92M | -0.40% | 958,359 | 1.23M |
| 386 | NRXS | NeurAxis, Inc. | 82.34M | 5.14% | 118,172 | 3.57M |
| 387 | GUTS | Fractyl Health, Inc. | 81.61M | -4.74% | 1,527,998 | 3.00K |
| 388 | ATYR | aTyr Pharma, Inc. | 81.43M | -1.45% | 613,392 | 190.00K |
| 389 | MAIA | MAIA Biotechnology, Inc. | 80.69M | -6.34% | 992,726 | - |
| 390 | PLRX | Pliant Therapeutics, Inc. | 80.49M | -0.76% | 401,131 | - |
| 391 | IMMP | Immutep Limited | 79.23M | 6.54% | 53,603,539 | 5.28M |
| 392 | LONA | LeonaBio, Inc. | 77.31M | -13.19% | 51,828 | - |
| 393 | PTHS | Pelthos Therapeutics Inc. | 77.18M | - | 24,721 | 16.80M |
| 394 | FBIO | Fortress Biotech, Inc. | 75.68M | -3.29% | 344,837 | 63.26M |
| 395 | XBIT | XBiotech Inc. | 74.09M | -1.22% | 17,618 | - |
| 396 | PMVP | PMV Pharmaceuticals, Inc. | 73.06M | -2.84% | 845,392 | - |
| 397 | IBIO | iBio, Inc. | 72.89M | 0.48% | 689,102 | 300.00K |
| 398 | IBO | Impact BioMedical Inc. | 71.50M | -1.89% | 112,693 | 32.00K |
| 399 | PDSB | PDS Biotechnology Corporation | 71.44M | -5.88% | 1,711,178 | - |
| 400 | MNOV | MediciNova, Inc. | 70.88M | 0.70% | 17,408 | 409.66K |
| 401 | ESLA | Estrella Immunopharma, Inc. | 70.82M | -4.05% | 28,750 | - |
| 402 | INKT | MiNK Therapeutics, Inc. | 70.17M | 9.20% | 103,691 | - |
| 403 | GRCE | Grace Therapeutics, Inc. | 69.48M | 2.98% | 619,757 | - |
| 404 | BYSI | BeyondSpring Inc. | 69.08M | -0.59% | 3,722 | 1.88M |
| 405 | ICCC | ImmuCell Corporation | 68.21M | -0.79% | 19,441 | 27.64M |
| 406 | HYFT | MindWalk Holdings Corp. | 65.56M | 3.13% | 232,798 | 20.70M |
| 407 | TCRX | TScan Therapeutics, Inc. | 64.91M | 0.93% | 1,244,477 | 10.33M |
| 408 | ACRV | Acrivon Therapeutics, Inc. | 64.70M | - | 422,857 | - |
| 409 | IMA | ImageneBio, Inc. | 64.65M | 2.30% | 62,293 | 800.00K |
| 410 | OKUR | OnKure Therapeutics, Inc. | 63.86M | 3.55% | 150,774 | - |
| 411 | ATHE | Alterity Therapeutics Limited | 62.36M | 6.43% | 10,290 | 4.43M |
| 412 | ANVS | Annovis Bio, Inc. | 61.47M | 1.14% | 851,646 | - |
| 413 | CING | Cingulate Inc. | 61.17M | 1.15% | 296,563 | - |
| 414 | TIL | Instil Bio, Inc. | 60.36M | 0.11% | 13,427 | - |
| 415 | CUE | Cue Biopharma, Inc. | 60.08M | -15.06% | 10,914,280 | 27.47M |
| 416 | OSTX | OS Therapies Incorporated | 58.85M | 1.45% | 321,647 | - |
| 417 | ENTX | Entera Bio Ltd. | 55.95M | 1.69% | 108,406 | 42.00K |
| 418 | KZR | Kezar Life Sciences, Inc. | 54.33M | -0.14% | 164,100 | - |
| 419 | MGX | Metagenomi Therapeutics, Inc. | 54.17M | - | 189,410 | 25.21M |
| 420 | DWTX | Dogwood Therapeutics, Inc. | 52.11M | -8.77% | 201,861 | - |
| 421 | MREO | Mereo BioPharma Group plc | 52.08M | -3.69% | 3,166,857 | 500.00K |
| 422 | ACTU | Actuate Therapeutics, Inc. | 50.98M | - | 112,093 | - |
| 423 | RADX | Radiopharm Theranostics Limited | 50.81M | -0.22% | 29,650 | 10.86M |
| 424 | NTRB | Nutriband Inc. | 49.72M | 0.25% | 9,600 | 2.28M |
| 425 | ATOS | Atossa Therapeutics, Inc. | 49.69M | 0.52% | 34,063 | - |
| 426 | XLO | Xilio Therapeutics, Inc. | 48.28M | -0.60% | 23,654 | 43.77M |
| 427 | RNTX | Rein Therapeutics Inc. | 47.67M | -4.49% | 87,160 | - |
| 428 | ALGS | Aligos Therapeutics, Inc. | 47.40M | 3.23% | 5,903,557 | 2.19M |
| 429 | TELO | Telomir Pharmaceuticals, Inc. | 46.07M | - | 88,608 | - |
| 430 | EDSA | Edesa Biotech, Inc. | 45.67M | -4.10% | 207,937 | - |
| 431 | RNXT | RenovoRx, Inc. | 45.05M | -1.96% | 190,491 | 1.12M |
| 432 | HYPD | Hyperion DeFi, Inc. | 44.54M | 1.30% | 371,775 | 813.46K |
| 433 | HOWL | Werewolf Therapeutics, Inc. | 44.30M | -0.87% | 79,458 | 1.14M |
| 434 | RLYB | Rallybio Corporation | 44.06M | 0.60% | 35,472 | 858.00K |
| 435 | LITS | Lite Strategy, Inc. | 42.91M | -1.67% | 158,490 | - |
| 436 | ATRA | Atara Biotherapeutics, Inc. | 42.85M | - | 34,824 | 120.77M |
| 437 | PSTV | Plus Therapeutics, Inc. | 40.83M | 5.31% | 340,880 | 5.21M |
| 438 | VERU | Veru Inc. | 39.64M | 1.65% | 40,578 | 16.89M |
| 439 | DARE | Daré Bioscience, Inc. | 39.60M | 51.96% | 3,226,389 | 1.03M |
| 440 | NXTC | NextCure, Inc. | 39.16M | -12.63% | 27,221 | - |
| 441 | SNSE | Sensei Biotherapeutics, Inc. | 39.16M | 0.03% | 16,250 | - |
| 442 | ATNM | Actinium Pharmaceuticals, Inc. | 38.97M | -0.79% | 130,231 | 90.00K |
| 443 | CVM | CEL-SCI Corporation | 37.55M | 5.94% | 31,516 | - |
| 444 | PASG | Passage Bio, Inc. | 37.47M | -1.77% | 30,724 | - |
| 445 | LIXT | Lixte Biotechnology Holdings, Inc. | 37.41M | 3.54% | 21,632 | - |
| 446 | CRVO | CervoMed Inc. | 36.94M | -1.24% | 18,147 | 4.01M |
| 447 | BOLD | Boundless Bio, Inc. | 36.52M | - | 255,185 | - |
| 448 | CELU | Celularity Inc. | 35.76M | -0.80% | 29,042 | 40.58M |
| 449 | INMB | INmune Bio Inc. | 35.62M | 1.52% | 208,926 | 50.00K |
| 450 | PLUR | Pluri Inc. | 35.28M | 1.45% | 40,728 | 1.34M |
| 451 | PTN | Palatin Technologies, Inc. | 35.00M | -4.08% | 14,798 | 8.96M |
| 452 | EVAX | Evaxion A/S | 34.53M | - | 34,459 | 7.53M |
| 453 | LGVN | Longeveron Inc. | 32.21M | -1.79% | 995,995 | 1.20M |
| 454 | TPST | Tempest Therapeutics, Inc. | 32.13M | 5.66% | 507,466 | - |
| 455 | DYAI | Dyadic International, Inc. | 31.96M | 0.19% | 51,568 | 3.09M |
| 456 | BCTX | BriaCell Therapeutics Corp. | 31.25M | -6.49% | 201,679 | - |
| 457 | IGC | IGC Pharma, Inc. | 30.76M | 0.31% | 690,838 | 1.11M |
| 458 | APLM | Apollomics, Inc. | 30.64M | - | - | 6.93M |
| 459 | LSTA | Lisata Therapeutics, Inc. | 30.44M | -15.96% | 204,360 | 170.00K |
| 460 | ABVC | ABVC BioPharma, Inc. | 30.39M | -6.11% | 86,420 | 797.92K |
| 461 | TVRD | Tvardi Therapeutics, Inc. | 30.21M | -7.20% | 71,359 | - |
| 462 | SNTI | Senti Biosciences, Inc. | 29.95M | 2.84% | 89,939 | 22.00K |
| 463 | KYNB | Kyntra Bio, Inc. | 29.10M | 0.98% | 8,713 | 6.44M |
| 464 | LTRN | Lantern Pharma Inc. | 28.47M | 4.96% | 738,249 | - |
| 465 | OTLK | Outlook Therapeutics, Inc. | 28.29M | -0.95% | 2,310,400 | 205.70K |
| 466 | JSPR | Jasper Therapeutics, Inc. | 27.04M | -8.01% | 541,551 | - |
| 467 | MRKR | Marker Therapeutics, Inc. | 26.84M | 1.90% | 67,452 | 3.55M |
| 468 | TVGN | Tevogen Bio Holdings Inc. | 26.48M | -1.24% | 11,978 | - |
| 469 | NEUP | Neuphoria Therapeutics Inc. | 25.45M | 1.51% | 11,017 | 14.99M |
| 470 | NNVC | NanoViricides, Inc. | 25.05M | -0.85% | 228,643 | - |
| 471 | SKYE | Skye Bioscience, Inc. | 25.03M | -2.98% | 250,696 | - |
| 472 | NRSN | NeuroSense Therapeutics Ltd. | 25.03M | -3.01% | 96,899 | - |
| 473 | AEON | AEON Biopharma, Inc. | 25.00M | 4.45% | 50,889 | - |
| 474 | XCUR | Exicure, Inc. | 24.59M | -2.50% | 6,795 | 500.00K |
| 475 | SER | Serina Therapeutics, Inc. | 24.51M | -1.97% | 50,954 | 130.00K |
| 476 | LEXX | Lexaria Bioscience Corp. | 24.42M | -4.37% | 102,425 | 368.00K |
| 477 | BRNS | Barinthus Biotherapeutics plc | 24.14M | -0.34% | 16,224 | 14.97M |
| 478 | VTGN | Vistagen Therapeutics, Inc. | 23.90M | -1.36% | 397,584 | 789.00K |
| 479 | CRIS | Curis, Inc. | 23.63M | -13.64% | 1,631,864 | 9.44M |
| 480 | QNCX | Quince Therapeutics, Inc. | 21.84M | 8.94% | 2,913,251 | - |
| 481 | COCP | Cocrystal Pharma, Inc. | 21.64M | 4.67% | 503,326 | - |
| 482 | VYNE | VYNE Therapeutics Inc. | 20.58M | -0.37% | 85,280 | 570.00K |
| 483 | ALLR | Allarity Therapeutics, Inc. | 19.62M | -0.80% | 100,841 | 320.00K |
| 484 | PLRZ | Polyrizon Ltd. | 19.50M | -1.80% | 29,777 | - |
| 485 | CTXR | Citius Pharmaceuticals, Inc. | 19.13M | -0.12% | 223,189 | 3.94M |
| 486 | LPCN | Lipocine Inc. | 18.69M | - | 354,751 | 1.98M |
| 487 | KTTA | Pasithea Therapeutics Corp. | 18.36M | -1.33% | 184,784 | - |
| 488 | OSRH | OSR Holdings, Inc. | 18.25M | 0.80% | 450,694 | 2.91M |
| 489 | QNTM | Quantum BioPharma Ltd. | 18.15M | 3.26% | 197,783 | - |
| 490 | GNTA | Genenta Science S.p.A. | 17.05M | 1.29% | 44,369 | - |
| 491 | TRAW | Traws Pharma, Inc. | 16.91M | -1.63% | 961,475 | 2.79M |
| 492 | ICU | SeaStar Medical Holding Corporation | 16.61M | 7.77% | 83,785 | 1.23M |
| 493 | HIND | Vyome Holdings, Inc. | 15.58M | -0.89% | 29,240 | 319.71K |
| 494 | PHIO | Phio Pharmaceuticals Corp. | 14.75M | -3.79% | 146,598 | - |
| 495 | JUNS | Jupiter Neurosciences, Inc. | 14.47M | 0.13% | 65,851 | 21.80K |
| 496 | INAB | IN8bio, Inc. | 14.28M | 3.57% | 89,866 | - |
| 497 | HOTH | Hoth Therapeutics, Inc. | 14.22M | 6.61% | 2,014,249 | - |
| 498 | INTS | Intensity Therapeutics, Inc. | 13.52M | 0.38% | 29,849 | - |
| 499 | PBM | Psyence Biomedical Ltd. | 13.46M | 103.82% | 53,763,240 | - |
| 500 | KAPA | Kairos Pharma, Ltd. | 13.09M | 1.92% | 92,746 | - |